Reducing GEF-H1 Expression Inhibits Renal Cyst Formation, Inflammation, and Fibrosis via RhoA Signaling in...

Area of Science:

• Nephrology
• Molecular Biology
• Pathogenesis Research

Background:

• Nephronophthisis (NPHP) is a leading genetic cause of childhood end-stage renal failure.
• RhoA activation is implicated in the pathogenesis of NPHP.
• The role of GEF-H1, a RhoA activator, in NPHP remains to be fully elucidated.

Purpose of the Study:

• To investigate the role of guanine nucleotide exchange factor (GEF)-H1 in the pathogenesis of Nephronophthisis (NPHP).
• To analyze the GEF-H1/RhoA/MLC2 signaling axis in NPHP models.

Main Methods:

• Utilized NPHP1 knockout (NPHP1^KO) mice and NPHP1 knockdown (NPHP1^KD) human kidney proximal tubular cells (HK2).
• Assessed GEF-H1 expression and distribution via Western blotting and immunofluorescence.
• Measured RhoA activation, GTP-RhoA, p-MLC2, E-cadherin, and α-smooth muscle actin (α-SMA) levels.

Main Results:

• Increased GEF-H1 expression, RhoA activation, and p-MLC2 levels were observed in NPHP1^KO mice and NPHP1^KD HK2 cells.
• NPHP1^KO mice exhibited renal cysts, fibrosis, and inflammation, which were reduced by GEF-H1 knockdown.
• GEF-H1 knockdown in NPHP1^KD HK2 cells reversed α-SMA increase and E-cadherin decrease.

Conclusions:

• The GEF-H1/RhoA/MLC2 axis is activated in NPHP.
• GEF-H1 plays a pivotal role in NPHP pathogenesis.
• Targeting the GEF-H1/RhoA/MLC2 pathway may offer therapeutic potential for NPHP.